Assay Detail
Functional
CHEMBL706817
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Compound was evaluated for in vitro activity against LOXIMV1 Melanoma cell lines (Human tumor cells )
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | LOX IMVI |
| Confidence | 1 — Organism |
| Curated By | Intermediate |
Publication
Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 3 | 8.61 | 9.64 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL18155 | — | — | 1 | 9.64 |
| CHEMBL34259 | METHOTREXATE | 4.0 | 1 | 7.58 |
| CHEMBL150607 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL18155 | — | IC50 | = | 0.23 | nM | 9.64 |
| CHEMBL34259 | METHOTREXATE | IC50 | = | 26.0 | nM | 7.58 |
| CHEMBL150607 | — | IC50 | < | 0.1 | nM | - |